NuGen Announces Closing of First Tranche of Private Placement of Units

NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) (“NuGen” or the “Company”) announces that it has closed the first tranche of a non-brokered private placement through the issuance of 2,500,000 units (“Units”) at a price of $0.05 per Unit for gross proceeds of $125,000 (the “Offering”). Each Unit is comprised of one common share (“Common Share”) of the Company and one Common Share purchase warrant (“Warrant”). Each Warrant entitles the holder thereof to purchase one Common Share for a period of sixty (60) months from the closing of the Offering at a price of $0.05 per Common Share. The proceeds of the offering will be used for general working capital purposes.

> Read More

NuGen M.D. Announces the Departure of its President and CEO and Immediate Appointment of New Interim Chief Executive Officer and Interim Chief Customer Officer

The Board of directors of NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) (“NuGen” or the “Company”), a leader in needle-free drug delivery, announces the departure of Mr. Michael Wright, President and Chief Executive Officer, effective immediately. Mr. Wright remains a director and a shareholder of the Company and will assist with the management transition. The Company wishes Mr. Wright good luck with his future endeavors.

> Read More

NuGen M.D. Announces the Launch of its InsuJet(TM) Needle-Free Injection Device in Canada

SOL-MILLENNIUM Medical Group (“Sol-Millennium” or “Sol-M”), a global healthcare company dedicated to the design, manufacturing, and distribution of high-quality medical devices and personal protective equipment for patients and clinicians around the world, has registered as an exhibitor at the 2022 Diabetes Canada/Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference, where it will launch the InsuJet™ product for Canada.

> Read More

NuGen M.D. Welcomes Erik Emerson to its Advisory Board

“Erik brings a creative approach to commercialization, patient engagement, and corporate partnerships,” said NuGen CEO Michael Wright. “We look forward to working with him and our growing advisory team as NuGen continues to develop our innovative medical delivery products.”

> Read More
Subscribe to News